Leukemia & lymphoma

Indexings	ncbi ulakbim sci
Short Name	Leuk Lymphoma
Abbreviated Name	leuk lymphoma
ISSN	1029-2403
Aim and Scope
URL
Author Instructions

Publications Per Year

Recent Articles (8 total)

2020

Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation.

Joshi, Maansi;Taper, John;Forsyth, Cecily;Rowlings, Philip;Campbell, Philip;Crispin, Philip;Harvey, Michael;Underhill, Craig;Bayley, Angela;Byth, Karen;Huang, Gillian;Hertzberg, Mark;

Vol. 61 , No. 1 , pp. 91-97

277 views DOI Abstract

2020

Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.

Fukuhara, Noriko;Yamamoto, Go;Tsujimura, Hideki;Chou, Takaaki;Shibayama, Hirohiko;Yanai, Tomoko;Shibuya, Kazunori;Izutsu, Koji;

Vol. 61 , No. 1 , pp. 176-180

275 views DOI

2018

'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.

Scott, Ashleigh;Weber, Nicholas;Tiley, Campbell;Taylor, Kerry;Taper, John;Harrison, Simon;Chan, Kah-Lok;Stark, Richard;Lee, Cindy;Morris, Kirk;Ho, P Joy;Dodds, Anthony;Ramanathan, Sundra;Ramakrishna, Raj;Watson, Anne-Marie;Auguston, Bradley;Kwok, Fiona;Quach, Hang;Warburton, Pauline;Rowlings, Philip;Mollee, Peter;

Vol. 59 , No. 6 , pp. 1514-1516

248 views DOI

2019

Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'

Mele G;Pastore D;Di Renzo N;Fragasso A;Guarini A;Mazza P;Musto P;Pavone V;Tarantini G;Curci P;Falcone AP;Mele A;Miccolis MR;Palazzo G;Palumbo G;Quinto AM;Reddiconto G;Rizzi R;Cascavilla N;Specchia G;Capalbo SF;;

Vol. 60 , No. 14 , pp. -

247 views Abstract

2013

Micafungin as empirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics.

Racil, Zdenek;Toskova, Martina;Kocmanova, Iva;Buresova, Lucie;Kouba, Michal;Drgona, Lubos;Masarova, Lucia;Guman, Tomas;Tothova, Elena;Gabzdilova, Julia;Forsterova, Kristina;Haber, Jan;Ziakova, Barbora;Bojtarova, Eva;Rolencova, Monika;Timilsina, Shira;Cetkovsky, Petr;Mayer, Jiri;

Vol. 54 , No. 5 , pp. 1042-7

238 views DOI Abstract

2019

Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

Salvi F;Luminari S;Tucci A;Massidda S;Liberati AM;Stelitano C;Zanni M;Re A;Centurioni R;Freilone R;Musuraca G;Nassi L;Patti C;Arcari A;Tani M;Pulsoni A;Pavone V;Volpetti S;Peli A;Evangelista A;Spina M;Ladetto M;Merli F;;

Vol. 60 , No. 12 , pp. -

202 views Abstract

2017

Altered expression pattern of SLAM family receptors on pathological B cells of patients with chronic lymphocytic leukemia.

Coma, Matus;Tothova, Elena;Guman, Tomas;Hajikova, Martina;Giertlova, Maria;Sarissky, Marek;

Vol. 58 , No. 7 , pp. 1726-1729

165 views DOI

2022

Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice.

Montoro, Maria Julia;Pomares, Helena;Coll, Rosa;Bernal Del Castillo, Teresa;Tormo, Mar;Jiménez, Ana;Brunet, Salut;Casaño, Javier;Oiartzabal, Itziar;Díez-Campelo, María;Ramos, Fernando;Romero, Rafael;Salido-Fiérrez, Eduardo;Pedro, Carmen;Bargay, Joan;Muñoz-Novas, Carolina;López, Rocío;Rafel, Montserrat;Valcárcel, David;, ;

, pp. 1-12

87 views DOI Abstract

Overall

Not Rated

Journament